| Literature DB >> 33523108 |
Alessia Gimelli1, Riccardo Liga2, Denis Agostini3, Frank M Bengel4, Sabine Ernst5, Fabien Hyafil6, Antti Saraste7,8, Arthur J H A Scholte9, Hein J Verberne10, Derk O Verschure10,11, Riemer H J A Slart12,13.
Abstract
Cardiac sympathetic activity plays a key role in supporting cardiac function in both health and disease conditions, and nuclear cardiac imaging has always represented the only way for the non-invasive evaluation of the functional integrity of cardiac sympathetic terminals, mainly through the use of radiopharmaceuticals that are analogues of norepinephrine and, in particular, with the use of 123I-mIBG imaging. This technique demonstrates the presence of cardiac sympathetic dysfunction in different cardiac pathologies, linking the severity of sympathetic nervous system impairment to adverse patient's prognosis. This article will outline the state-of-the-art of cardiac 123I-mIBG imaging and define the value and clinical applications in the different fields of cardiovascular diseases. Published on behalf of the European Society of Cardiology. All rights reserved.Entities:
Keywords: MIBG; cardiac innervation; molecular imaging; nuclear cardiology
Mesh:
Substances:
Year: 2021 PMID: 33523108 DOI: 10.1093/ehjci/jeab007
Source DB: PubMed Journal: Eur Heart J Cardiovasc Imaging ISSN: 2047-2404 Impact factor: 6.875